Long-term survival outcomes of systemic therapy in patients with isolated and mixed medullary thyroid cancer.

The use of systemic therapy was also higher in the mixed MTC cohort, though it has borderline significance (62.8 % vs. 53.3 %, p = 0.052) ( Table 3 ).

also in 7,017 other papers